WRA is pleased to announce the founding of its new affiliate group, Rheumatologists in Early Career (REC), for physicians within the first ten years of the practice of rheumatology in Washington State as well as those still in training.  To be added to the REC mailing list, please contact Debra Alderman, WRA executive director:  wra@warheumatology.org.

WRA Rheumatologists in Early Career (REC) presents its inaugural event on Saturday, April 29 immediately after the conclusion of the Northwest Rheumatism Society’s annual conference.

Join your colleagues for a delicious lunch and CME talk with Dr. Nancy Lane

Dear WRA Members and Colleagues,

The Washington Rheumatology Alliance is pleased to invite you to a free opportunity to enjoy a delicious lunch and CME talk on Saturday, April 29, 2017 immediately following the adjournment of the Northwest Rheumatism Society meeting.

The Washington Rheumatology Alliance is teaming up with ARTHROS to present City Rounds, a unique educational initiative designed to provide up-and-coming rheumatologists, nurse practitioners and physician assistants a chance to interact with leaders in the treatment of RA in a round-table format.

The round-table meeting is a one-of-a-kind program designed to be a discussion amongst peers and experts in RA treatment. The discussion will be enhanced by educational resources which will reinforce key learning take-aways that you can use in your clinical practice and beyond. Please join us for this unique and informative event.

Date: April 29, 2017

Time: 12 noon registration and social time; 12:30 lunch and program

Venue: Wild Ginger restaurant, 508 Bellevue Way, Bellevue, WA
(Located in the Lincoln Square South  complex — just a couple of blocks south of the Hyatt Regency Bellevue where the Northwest Rheumatism Society conference will be held).

Guest speaker:  
Nancy Lane, MD
UC Davis Health System
Sacramento, CA

This program is provided free of charge and includes a delicious lunch and CME program.

To register go directly to this registration page.

Goal Statement:
The goal of this program is to provide important clinical data on issues related to the management of RA.

Target Audience:
This educational program is targeted at physicians and other healthcare providers who specialize in the management of patients with RA.
Learning Objectives:
After completing this activity, the participants should be better able to:
•    Develop an evidence-based treatment regimen using the latest clinical evidence
•    Explain the disease and the treatment options to patients
•    Recognize and communicate the risks and benefits of RA therapy
•    Identify barriers to optimal management of patients with RA

Physician Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of Purdue University College of Pharmacy and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:
Purdue University College of Pharmacy designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Support Statement:
This activity is supported by educational grants from AbbVie, Inc., Janssen-Biotech, Inc., Pfizer Inc., and Sanofi-aventis US.

Disclosure Statement:
All faculty AND staff involved in the planning, review or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All additional planning committee members, reviewers and Purdue University College of Pharmacy staff have no relationships to disclose.

Nancy Lane, MD
Dr. Lane has received research support from Amgen, Alexion, Gilead Sciences Inc., and Pfizer. She has been a consultant or on a speaker bureau for Amgen, Novartis, and Regeneron. Dr. Lane has also been an advisor for Amgen and Regeneron. She has been on the Editorial Board for Seminars Arthritis and Rheumatism.